Given Imaging Ltd. Release: Study Confirms PillCam(R) COLON’s Potential as a Complement to Colonoscopy to Increase Colo-Rectal Screenings

YOQNEAM, ISRAEL and SAN DIEGO, CA--(Marketwire - May 19, 2008) - Given Imaging Ltd. (NASDAQ: GIVN) today announced the results of an eight-center European study confirmed that PillCam® COLON demonstrates encouraging results for detecting colo-rectal polyps compared to colonoscopy. The results were presented at the Digestive Disease Week® (DDW) 2008 conference taking place in San Diego. The prospective study was led by Jacques Deviere, M.D., Erasme Hospital in Brussels.
MORE ON THIS TOPIC